Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria~* Patients with clinical CL symptoms for less than 6 months with the diagnosis confirmed by microscopic visualisation of Leishmania parasites in skin scrape smear.~* Patients who have given written informed consent.~Exclusion criteria~* Patients presenting with CL lesions located on or within two centimetres of eyes and lips.~* Patients with more than four lesions.~* Lesions, nodules and/or ulcerations with a diameter (ø) of more than 6 cm.~* Patients with persistent lesions for more than 6 months.~* Patients younger than 10 years.~* Patients who are unlikely, unable or unwilling to be available for and comply to regular follow up visits for 6 months.~* Pregnant, and lactating women \<6 months after delivery.~* Patients with uncontrolled medical illnesses.~* Patients with immune disorders, such as HIV/AIDS, or those who are on steroid medication

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- HECT-CL (Type: EXPERIMENTAL): HECT-CL heat pack will be applied on CL lesions (50-52 degrees Celsius for 3 minutes on 7 consecutive days)

Based on this trial design, predict the completion outcome and termination type (if applicable).